158 related articles for article (PubMed ID: 36859353)
1. A radiomics model for predicting the response to methylprednisolone in brain necrosis after radiotherapy for nasopharyngeal carcinoma.
Zhuo X; Zhao H; Chen M; Mu Y; Li Y; Cai J; Li H; Xu Y; Tang Y
Radiat Oncol; 2023 Mar; 18(1):43. PubMed ID: 36859353
[TBL] [Abstract][Full Text] [Related]
2. MRI-based radiomics nomogram for predicting temporal lobe injury after radiotherapy in nasopharyngeal carcinoma.
Hou J; Li H; Zeng B; Pang P; Ai Z; Li F; Lu Q; Yu X
Eur Radiol; 2022 Feb; 32(2):1106-1114. PubMed ID: 34467454
[TBL] [Abstract][Full Text] [Related]
3. A Radiomics Model for Predicting the Response to Bevacizumab in Brain Necrosis after Radiotherapy.
Cai J; Zheng J; Shen J; Yuan Z; Xie M; Gao M; Tan H; Liang Z; Rong X; Li Y; Li H; Jiang J; Zhao H; Argyriou AA; Chua MLK; Tang Y
Clin Cancer Res; 2020 Oct; 26(20):5438-5447. PubMed ID: 32727886
[TBL] [Abstract][Full Text] [Related]
4. A MRI-based radiomics model predicting radiation-induced temporal lobe injury in nasopharyngeal carcinoma.
Bao D; Zhao Y; Li L; Lin M; Zhu Z; Yuan M; Zhong H; Xu H; Zhao X; Luo D
Eur Radiol; 2022 Oct; 32(10):6910-6921. PubMed ID: 35639143
[TBL] [Abstract][Full Text] [Related]
5. Baseline MRI-based radiomics model assisted predicting disease progression in nasopharyngeal carcinoma patients with complete response after treatment.
Bao D; Liu Z; Geng Y; Li L; Xu H; Zhang Y; Hu L; Zhao X; Zhao Y; Luo D
Cancer Imaging; 2022 Jan; 22(1):10. PubMed ID: 35090572
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging-based radiomics model for predicting radiation-induced temporal lobe injury in nasopharyngeal carcinoma after intensity-modulated radiotherapy.
Bao D; Zhao Y; Liu Z; Xu H; Zhang Y; Yuan M; Li L; Lin M; Zhao X; Luo D
Head Neck; 2022 Dec; 44(12):2842-2853. PubMed ID: 36161397
[TBL] [Abstract][Full Text] [Related]
7. Nomogram Based on Clinical and Radiomics Data for Predicting Radiation-induced Temporal Lobe Injury in Patients with Non-metastatic Stage T4 Nasopharyngeal Carcinoma.
Bin X; Zhu C; Tang Y; Li R; Ding Q; Xia W; Tang Y; Tang X; Yao D; Tang A
Clin Oncol (R Coll Radiol); 2022 Dec; 34(12):e482-e492. PubMed ID: 36008245
[TBL] [Abstract][Full Text] [Related]
8. Cervical spine osteoradionecrosis or bone metastasis after radiotherapy for nasopharyngeal carcinoma? The MRI-based radiomics for characterization.
Zhong X; Li L; Jiang H; Yin J; Lu B; Han W; Li J; Zhang J
BMC Med Imaging; 2020 Sep; 20(1):104. PubMed ID: 32873238
[TBL] [Abstract][Full Text] [Related]
9. Radiomics model based on preoperative gadoxetic acid-enhanced MRI for predicting liver failure.
Zhu WS; Shi SY; Yang ZH; Song C; Shen J
World J Gastroenterol; 2020 Mar; 26(11):1208-1220. PubMed ID: 32231424
[TBL] [Abstract][Full Text] [Related]
10. Prediction of Changes in Tumor Regression during Radiotherapy for Nasopharyngeal Carcinoma by Using the Computed Tomography-Based Radiomics.
Yang Y; Wu J; Mai W; Li H
Contrast Media Mol Imaging; 2022; 2022():3417480. PubMed ID: 36226269
[TBL] [Abstract][Full Text] [Related]
11. Machine Learning-Based Radiomics Predicts Radiotherapeutic Response in Patients With Acromegaly.
Fan Y; Jiang S; Hua M; Feng S; Feng M; Wang R
Front Endocrinol (Lausanne); 2019; 10():588. PubMed ID: 31507537
[No Abstract] [Full Text] [Related]
12. Radiomic signatures reveal multiscale intratumor heterogeneity associated with tissue tolerance and survival in re-irradiated nasopharyngeal carcinoma: a multicenter study.
Liu T; Dong D; Zhao X; Ou XM; Yi JL; Guan J; Zhang Y; Xiao-Fei L; Xie CM; Luo DH; Sun R; Chen QY; Xing L; Guo SS; Liu LT; Lin DF; Chen YZ; Lin JY; Luo MJ; Yan WB; He ML; Mao MY; Zhu MY; Chen WH; Shen BW; Wang SQ; Li HL; Zhong LZ; Hu CS; Wu DH; Mai HQ; Tian J; Tang LQ
BMC Med; 2023 Nov; 21(1):464. PubMed ID: 38012705
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of an MRI-based radiomic model for predicting overall survival in nasopharyngeal carcinoma patients with local residual tumors after intensity-modulated radiotherapy.
Jiang S; Han L; Liang L; Long L
BMC Med Imaging; 2022 Oct; 22(1):174. PubMed ID: 36195860
[TBL] [Abstract][Full Text] [Related]
14. Comparison between high-dose and low-dose intravenous methylprednisolone therapy in patients with brain necrosis after radiotherapy for nasopharyngeal carcinoma.
Zhuo X; Huang X; Yan M; Li H; Li Y; Rong X; Lin J; Cai J; Xie F; Xu Y; Chen K; Tang Y
Radiother Oncol; 2019 Aug; 137():16-23. PubMed ID: 31048233
[TBL] [Abstract][Full Text] [Related]
15. Prediction of osteoporosis using radiomics analysis derived from single source dual energy CT.
Wang J; Zhou S; Chen S; He Y; Gao H; Yan L; Hu X; Li P; Shen H; Luo M; You T; Li J; Zhong Z; Zhang K
BMC Musculoskelet Disord; 2023 Feb; 24(1):100. PubMed ID: 36750927
[TBL] [Abstract][Full Text] [Related]
16. Radiomics Analysis for Evaluation of Pathological Complete Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.
Liu Z; Zhang XY; Shi YJ; Wang L; Zhu HT; Tang Z; Wang S; Li XT; Tian J; Sun YS
Clin Cancer Res; 2017 Dec; 23(23):7253-7262. PubMed ID: 28939744
[No Abstract] [Full Text] [Related]
17. Pretreatment MR imaging radiomics signatures for response prediction to induction chemotherapy in patients with nasopharyngeal carcinoma.
Wang G; He L; Yuan C; Huang Y; Liu Z; Liang C
Eur J Radiol; 2018 Jan; 98():100-106. PubMed ID: 29279146
[TBL] [Abstract][Full Text] [Related]
18. A nomogram for the prediction of cerebrovascular disease among patients with brain necrosis after radiotherapy for nasopharyngeal carcinoma.
Cai J; Cheng J; Li H; Lin WJ; Li Y; Zhuo X; Huang X; Simone CB; Aronow WS; Chow ELW; Tang Y
Radiother Oncol; 2019 Mar; 132():34-41. PubMed ID: 30825967
[TBL] [Abstract][Full Text] [Related]
19. Development and multicenter validation of a CT-based radiomics signature for predicting severe COVID-19 pneumonia.
Li L; Wang L; Zeng F; Peng G; Ke Z; Liu H; Zha Y
Eur Radiol; 2021 Oct; 31(10):7901-7912. PubMed ID: 33786655
[TBL] [Abstract][Full Text] [Related]
20. A radiomics approach to predict lymph node metastasis and clinical outcome of intrahepatic cholangiocarcinoma.
Ji GW; Zhu FP; Zhang YD; Liu XS; Wu FY; Wang K; Xia YX; Zhang YD; Jiang WJ; Li XC; Wang XH
Eur Radiol; 2019 Jul; 29(7):3725-3735. PubMed ID: 30915561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
